Table 2 Antimicrobial susceptibilities of Acinetobacter species causing invasive infections in children
No. of cases (%) | |||
|---|---|---|---|
Non-AB (n = 48) | AB non-CC92 (n = 8) | AB CC92 (n = 52) | |
Ceftazidime | 41 (85.4)) | 8 (100) | 1 (1.9) |
Cefepime | 43 (89.6) | 7 (87.5) | 1 (1.9) |
PIP/TAZ | 41 (85.4)) | 7 (87.5) | 1 (1.9) |
Imipenem | 47 (97.9) | 7 (87.5) | 3 (5.8) |
Amikacin | 44 (91.7) | 8 (100) | 12 (23.1) |
Ciprofloxacin | 47 (97.9) | 8 (100) | 1 (1.9) |
TMP/SMZ | 38 (79.2) | 7 (87.5) | 6 (11.5) |
Colistin | - | 3 (37.5) | 21 (40.4) |